SBC Medical Group Holdings Inc 最近的每股盈餘為 $0.11,超出預期 $0.09 的預期。
SBC Medical Group Holdings Inc SBC 上一季度的收入表現如何?
SBC Medical Group Holdings Inc 上一季度的收入為 $0.11
SBC Medical Group Holdings Inc 的收入預期是多少?
根據 6 位華爾街分析師的預測,SBC Medical Group Holdings Inc 的收入預期範圍從 $48.71M 到 $42.82M
SBC Medical Group Holdings Inc 的盈利品質評分是多少?
SBC Medical Group Holdings Inc 的盈利品質評分為 B+/55.770195。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。
SBC Medical Group Holdings Inc 何時發布財報?
SBC Medical Group Holdings Inc 的下一份財報預計在 2026-08-12 發布
SBC Medical Group Holdings Inc 的預期收益是多少?
根據華爾街分析師的預測,SBC Medical Group Holdings Inc 的預期收益為 $42.07M
SBC Medical Group Holdings Inc 是否超出收益預期?
SBC Medical Group Holdings Inc 最近的收益為 $43.06M,超出預期 預期。
關鍵數據
前收市價
$3.07
開盤價
$3.07
當日範圍
$3 - $3.11
52週區間
$2.97 - $5.75
交易量
61.4K
平均成交量
65.1K
股息收益率
--
每股盈餘 (TTM)
0.50
市值
$307.7M
什麼是 SBC?
SBC Medical Group Holdings, Inc. engages in management services and products to cosmetic treatment centers. The company is headquartered in Irvine, California and currently employs 863 full-time employees. The company went IPO on 2022-09-26. The firm is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.